Drugs / NDC-002C
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06090474 | Jan → Mar 2023 | stroke disorder | Dr. Noah Biotech Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NDC-002C | “Combination of NDC-002B and NDC-002C” NCT06090474 ↗ |